ArticleWorld journal of cardiology2025

Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.